메뉴 건너뛰기




Volumn 23, Issue 3, 2011, Pages 293-298

Treatment with biologics of pregnant patients with rheumatic diseases

Author keywords

biological drugs; pregnancy; rheumatic disease

Indexed keywords

ABATACEPT; ADALIMUMAB; ANTIRHEUMATIC AGENT; CERTOLIZUMAB; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

EID: 79955017825     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e328344a732     Document Type: Review
Times cited : (38)

References (42)
  • 1
    • 0029087201 scopus 로고
    • Transport of immunoglobulinG and its subclasses across the in vitro-perfused human placenta
    • Malek A, Sager R, Zakher A, Schneider H. Transport of immunoglobulinG and its subclasses across the in vitro-perfused human placenta. Am J Obestet Gynecol 1995; 173:760-767.
    • (1995) Am J Obestet Gynecol , vol.173 , pp. 760-767
    • Malek, A.1    Sager, R.2    Zakher, A.3    Schneider, H.4
  • 2
    • 55849132798 scopus 로고    scopus 로고
    • Effects of structure of conventional anti-TNFs and certolizumab pegol on mode of action in rheumatoid arthritis
    • Nesbitt A, Fossati G, Brown D, et al. Effects of structure of conventional anti-TNFs and certolizumab pegol on mode of action in rheumatoid arthritis. Ann Rheum Dis 2007; 66 (Suppl 2):296.
    • (2007) Ann Rheum Dis , vol.66 , Issue.SUPPL. 2 , pp. 296
    • Nesbitt, A.1    Fossati, G.2    Brown, D.3
  • 3
    • 77952501401 scopus 로고    scopus 로고
    • Pregnancy outcomes in women exposed to etanercept: The OTIS autoimmune diseases in pregnancy project
    • Johnson DL, Jones KL, Chambers C. Pregnancy outcomes in women exposed to etanercept: the OTIS autoimmune diseases in pregnancy project. Arthritis Rheum 2008; 58 (Suppl 9):S682.
    • (2008) Arthritis Rheum , vol.58 , Issue.SUPPL. 9
    • Johnson, D.L.1    Jones, K.L.2    Chambers, C.3
  • 4
    • 79954988597 scopus 로고    scopus 로고
    • Pregnancy outcomes in women exposed to adalimumab
    • Johnson D, Jones K, Chambers C. Pregnancy outcomes in women exposed to adalimumab. Can J Gastroenterol 2009; 23 (Suppl SA):34.
    • (2009) Can J Gastroenterol , vol.23 , Issue.SUPPL. SA , pp. 34
    • Johnson, D.1    Jones, K.2    Chambers, C.3
  • 5
    • 65649134752 scopus 로고    scopus 로고
    • A safety assessment of tumor necrosis factor antagonists during pregnancy: A review of the Food and Drug Administration database
    • Carter JD, Ladhani A, Ricca LR, et al. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol 2009; 36:635-641.
    • (2009) J Rheumatol , vol.36 , pp. 635-641
    • Carter, J.D.1    Ladhani, A.2    Ricca, L.R.3
  • 6
    • 58749115377 scopus 로고    scopus 로고
    • Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature
    • Berthelot JM, De Bandt M, Goupille P, et al. Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature. Joint Bone Spine 2009; 76:28-34.
    • (2009) Joint Bone Spine , vol.76 , pp. 28-34
    • Berthelot, J.M.1    De Bandt, M.2    Goupille, P.3
  • 7
    • 33745634096 scopus 로고    scopus 로고
    • Cytokines and pregnancy in rheumatic disease
    • 1stensen M, Fö rger F, Villiger PM. Cytokines and pregnancy in rheumatic disease. Ann N Y Acad Sci 2006; 1069:353-363.
    • (2006) Ann N y Acad Sci , vol.1069 , pp. 353-363
    • Istensen, M.F.1
  • 8
    • 11144254079 scopus 로고    scopus 로고
    • Tumor necrosis factor receptor 1 expression and early spontaneous abortion
    • Yu XW, Yan CF, Jin HL, Li X. Tumor necrosis factor receptor 1 expression and early spontaneous abortion. Int J Gynecol and Obstet 2005; 88: 77-79.
    • (2005) Int J Gynecol and Obstet , vol.88 , pp. 77-79
    • Yu, X.W.1    Yan, C.F.2    Jin, H.L.3    Li, X.4
  • 9
    • 58249141891 scopus 로고    scopus 로고
    • Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF
    • Winger EE, Reed JL, Ashoush S, et al. Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol 2009; 61:113-120.
    • (2009) Am J Reprod Immunol , vol.61 , pp. 113-120
    • Winger, E.E.1    Reed, J.L.2    Ashoush, S.3
  • 10
    • 59249087444 scopus 로고    scopus 로고
    • Clinical experience with intravenous immunoglobulin and TNF - A inhibitor therapies for recurrent pregnancy loss
    • Sills ES, Walsh DJ, Shkrobot LV, et al. Clinical experience with intravenous immunoglobulin and TNF-a inhibitor therapies for recurrent pregnancy loss. Ulster Med J 2009; 78:57-58.
    • (2009) Ulster Med J , vol.78 , pp. 57-58
    • Sills, E.S.1    Walsh, D.J.2    Shkrobot, L.V.3
  • 11
    • 77958094698 scopus 로고    scopus 로고
    • First successful pregnancy after addition of enoxaparin to sildenafil and etanercept immunotherapy in woman with fifteen failed IVF cycles: Case report
    • Jerzak M, Niemiec T, Nowakowska A, et al. First successful pregnancy after addition of enoxaparin to sildenafil and etanercept immunotherapy in woman with fifteen failed IVF cycles: case report. Am J Reprod Immunol 2010; 64:93-96.
    • (2010) Am J Reprod Immunol , vol.64 , pp. 93-96
    • Jerzak, M.1    Niemiec, T.2    Nowakowska, A.3
  • 12
    • 76649111042 scopus 로고    scopus 로고
    • Treatment of psoriasis with anti-TNF drugs during pregnancy: Case report and review of the literature
    • Puig L, Barco D, Alomar A. Treatment of psoriasis with anti-TNF drugs during pregnancy: case report and review of the literature. Dermatology 2010; 220:71-76.
    • (2010) Dermatology , vol.220 , pp. 71-76
    • Puig, L.1    Barco, D.2    Alomar, A.3
  • 13
    • 67650992265 scopus 로고    scopus 로고
    • Absence of Infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery
    • Kane S, Ford J, Cohen R, Wagner C. Absence of Infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery. J Clin Gastroenterol 2009; 43:613-616.
    • (2009) J Clin Gastroenterol , vol.43 , pp. 613-616
    • Kane, S.1    Ford, J.2    Cohen, R.3    Wagner, C.4
  • 14
    • 34848824250 scopus 로고    scopus 로고
    • Infliximab levels in infants born to women with inflammatory bowel disease
    • 959
    • Mahadevan U, Terdiman JP, Church J, et al. Infliximab levels in infants born to women with inflammatory bowel disease. Gastroenterology 2007; 132 (Suppl 1):A 144:959.
    • (2007) Gastroenterology , vol.132 , Issue.SUPPL. 1
    • Mahadevan, U.1    Terdiman, J.P.2    Church, J.3
  • 16
    • 0035164357 scopus 로고    scopus 로고
    • Complementary effects of TNF and lymphotoxin on the formation of germinal center and follicular dendritic cells
    • Wang Y, Wang J, Sun Y, et al. Complementary effect of TNF and lymphotoxin on the formation of germinal center and follicular dendritic cells. J Immunol 2001; 166:330-337. (Pubitemid 32038449)
    • (2001) Journal of Immunology , vol.166 , Issue.1 , pp. 330-337
    • Wang, Y.1    Wang, J.2    Sun, Y.3    Wu, Q.4    Fu, Y.-X.5
  • 17
    • 77958150896 scopus 로고    scopus 로고
    • Case report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease
    • Cheent K, Nolan J, Shariq S, et al. Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohn's Colitis 2010; 4:603-605.
    • (2010) J Crohn's Colitis , vol.4 , pp. 603-605
    • Cheent, K.1    Nolan, J.2    Shariq, S.3
  • 18
    • 75749106673 scopus 로고    scopus 로고
    • A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment
    • Umeda N, Ito S, Hayashi T, et al. A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment. Intern Med 2010; 49:187-189.
    • (2010) Intern Med , vol.49 , pp. 187-189
    • Umeda, N.1    Ito, S.2    Hayashi, T.3
  • 19
    • 78650170917 scopus 로고    scopus 로고
    • Conception and course of eight pregnancies in five women on TNF blocker etanercept treatment
    • [Epub ahead of print]
    • Rump JA, Schö nborn H. Conception and course of eight pregnancies in five women on TNF blocker etanercept treatment. Z Rheumatol 2010 [Epub ahead of print].
    • (2010) Z Rheumatol
    • Rump, J.A.1    Schönborn, H.2
  • 20
    • 70449706430 scopus 로고    scopus 로고
    • Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: Drug levels in maternal serum, cord blood, breast milk and the infant's serum
    • Murashima A, Watanabe N, Ozawa N, et al. Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum. Ann Rheum Dis 2009; 68:1793-1794.
    • (2009) Ann Rheum Dis , vol.68 , pp. 1793-1794
    • Murashima, A.1    Watanabe, N.2    Ozawa, N.3
  • 21
    • 77949884124 scopus 로고    scopus 로고
    • Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: A comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR
    • Suzuki T, Ishii-Watabe A, Tada M, et al. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR. J Immunol 2010; 184:1968-1976.
    • (2010) J Immunol , vol.184 , pp. 1968-1976
    • Suzuki, T.1    Ishii-Watabe, A.2    Tada, M.3
  • 25
    • 84856720051 scopus 로고    scopus 로고
    • Certolizumab pegol use in pregnancy: Low levels detected in cord blood
    • Nov Suppl Annual Congress Abstract 718
    • Wolf D, Mahadevan U. Certolizumab pegol use in pregnancy: low levels detected in cord blood. Arthritis Rheum 2010; Nov Suppl, Annual Congress, Abstract 718.
    • (2010) Arthritis Rheum
    • Wolf, D.1    Mahadevan, U.2
  • 26
    • 77957281706 scopus 로고    scopus 로고
    • Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis
    • Villiger PM, Caliezi G, Cottin V, et al. Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis. Ann Rheum Dis 2010; 69:1842-1844.
    • (2010) Ann Rheum Dis , vol.69 , pp. 1842-1844
    • Villiger, P.M.1    Caliezi, G.2    Cottin, V.3
  • 31
    • 33746462344 scopus 로고    scopus 로고
    • Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy
    • DOI 10.1016/S1470-2045(06)70797-5, PII S1470204506707975
    • Decker M, Rothermundt C, Hollä nder G, et al. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncol 2006; 7:693-694. (Pubitemid 44123581)
    • (2006) Lancet Oncology , vol.7 , Issue.8 , pp. 693-694
    • Decker, M.1    Rothermundt, C.2    Hollander, G.3    Tichelli, A.4    Rochlitz, C.5
  • 32
    • 47349116535 scopus 로고    scopus 로고
    • Rituximab administration in third trimester pregnancy suppress neonatal B-cell development
    • Klink DT, Van Elburg RM, Schreurs MWJ, Van Well GTJ. Rituximab administration in third trimester pregnancy suppress neonatal B-cell development. Clin Dev Immunol 2008; 2008:271363.
    • (2008) Clin Dev Immunol , vol.2008 , pp. 271363
    • Klink, D.T.1    Van Elburg, R.M.2    Mwj, S.3    Van Well Gtj4
  • 33
    • 69549092122 scopus 로고    scopus 로고
    • Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab
    • Pellkofer HL, Suessmair C, Schulze A, et al. Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab. Multiple Sclerosis 2009; 15:1006-1008.
    • (2009) Multiple Sclerosis , vol.15 , pp. 1006-1008
    • Pellkofer, H.L.1    Suessmair, C.2    Schulze, A.3
  • 34
    • 58549103095 scopus 로고    scopus 로고
    • Rituximab combined with chemotherapy for lymphoma during pregnancy
    • Rey J, Coso D, Roger V, et al. Rituximab combined with chemotherapy for lymphoma during pregnancy. Leuk Res 2009; 33:e8-e9.
    • (2009) Leuk Res , vol.33
    • Rey, J.1    Coso, D.2    Roger, V.3
  • 35
    • 79955013746 scopus 로고    scopus 로고
    • Successful pregnancy after rituximab in a woman with recurrent in vitro fertilisation failures and antiphospholipid antibody
    • Ng CT, O'Neil M, Walsh D, et al. Successful pregnancy after rituximab in a woman with recurrent in vitro fertilisation failures and antiphospholipid antibody. Ir J Med Sci 2009; 178:531-533.
    • (2009) Ir J Med Sci , vol.178 , pp. 531-533
    • Ng, C.T.1    O'Neil, M.2    Walsh, D.3
  • 36
    • 79551653340 scopus 로고    scopus 로고
    • Rituximab and pregnancy: Safe before conception? A case report and a review of the literature
    • Abstract AB0229
    • Ton E, Tekstra J, Hellman PM, Bijlsma JWJ. Rituximab and pregnancy: safe before conception? A case report and a review of the literature. Ann Rheum Dis 2009; 68 (Abstract AB0229).
    • (2009) Ann Rheum Dis , vol.68
    • Ton, E.1    Tekstra, J.2    Hellman, P.M.3    Jwj, B.4
  • 37
    • 77955296598 scopus 로고    scopus 로고
    • Apparent safe use of a single dose rituximab for recalcitrant atopic dermatitis in the first trimester of a twin pregnancy
    • Ponte P, Lopes MJP. Apparent safe use of a single dose rituximab for recalcitrant atopic dermatitis in the first trimester of a twin pregnancy. J Am Acad Dermatol 2010; 63:355-356.
    • (2010) J Am Acad Dermatol , vol.63 , pp. 355-356
    • Ponte, P.1    Mjp, L.2
  • 38
    • 79953125573 scopus 로고    scopus 로고
    • Pregnancy outcomes following maternal exposure to rituximab
    • [Epub ahead of print]
    • Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes following maternal exposure to rituximab. Blood 2010 [Epub ahead of print].
    • (2010) Blood
    • Chakravarty, E.F.1    Murray, E.R.2    Kelman, A.3    Farmer, P.4
  • 39
    • 58849146669 scopus 로고    scopus 로고
    • Rituximab (MabThera) therapy and safety management. clinical tool guide
    • Pham T, Fautrel B, Gottenberg JE, et al. Rituximab (MabThera) therapy and safety management. clinical tool guide. Joint Bone Spine 2008; 75 (Suppl 1):S1-S99.
    • (2008) Joint Bone Spine , vol.75 , Issue.SUPPL. 1
    • Pham, T.1    Fautrel, B.2    Gottenberg, J.E.3
  • 42
    • 84926433002 scopus 로고    scopus 로고
    • First experiences with pregnancies in RA patients receiving tocilizumab therapy
    • Abstract 384 Nov Suppl: Annual Congress
    • Rubbert-Roth A, Goupille PM, Moosavi S, Hou A. First experiences with pregnancies in RA patients receiving tocilizumab therapy. Arthritis Rheum 2010; Nov Suppl: Annual Congress, Abstract 384.
    • (2010) Arthritis Rheum
    • Rubbert-Roth, A.1    Goupille, P.M.2    Moosavi, S.3    Hou, A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.